Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
33.47
-0.30 (-0.89%)
Jul 28, 2026, 3:20 PM EDT - Market open

Immunocore Holdings Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
412.81400.02310.2249.4333.6736.48
Revenue Growth
23.75%28.95%24.37%640.71%-7.70%-11.39%
Gross Profit
412.81394.93307.47248.3932.5936.48
Operating Income
-34.46-45.35-70.46-59.65-51.71-174.59
Net Income
3.74-2.69-54.79-66.49-52.54-180.03
Earnings Per Share
-0.55-0.71-1.02-1.13-1.15-4.24
EPS Growth
------

Revenue by Geography

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
United States
267.83257226.69169.7996.89-
Europe
133.03131.4273.2267.6342.754.08
International
11.9511.610.081.321.05-
Total
412.81400.02309.99238.74140.694.08

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
844.9864.15820.38442.63402.47321.62
Total Debt
435.68436.69432.7285.0181.4586.31
Net Cash (Debt)
409.21427.47387.65357.62321.02235.31
Net Cash Growth
1.53%10.27%8.40%11.40%36.42%161.46%
Net Cash Per Share
8.028.497.757.317.025.54

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-24.92-10.7126.062.94-49.21-143.11
Capital Expenditures
-5.82-4.34-5.17-5.43-2.2-1.39
Free Cash Flow
-30.75-15.0520.89-2.49-51.41-144.49
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%98.73%99.12%99.58%96.77%100.00%
Operating Margin
-8.35%-11.34%-22.71%-23.91%-153.56%-478.53%
Pretax Margin
-2.89%-4.77%-17.07%-24.41%-121.41%-493.04%
Profit Margin
0.91%-0.67%-17.66%-26.66%-156.03%-493.03%
FCF Margin
-7.45%-3.76%6.73%-1.00%-152.68%-396.04%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
--70.71---
PS Ratio
4.094.404.7613.6281.5041.17